Mittie Doyle
Chief Medical Officer; Director · 14 filings · Latest: Aug 10, 2026
Avalo Therapeutics, Inc.
Cullinan Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AVTX | MITTIE DOYLE | — | Apr 6, 2026 | Proposed Sale | $17.76 | 65,800 | $1.2M | — | |
AVTX | Mittie Doyle | Chief Medical Officer | Apr 1, 2026 | Sale | $16.00 | 679 | $10.9K | 3,622 | |
AVTX | Mittie Doyle | Chief Medical Officer | Apr 1, 2026 | Option Exercise | $8.04 | 679 | $5.5K | 4,301 | |
AVTX | Mittie Doyle | Chief Medical Officer | Mar 16, 2026 | Sale | $16.15 | 25,492 | $411.6K | 3,622 | |
AVTX | Mittie Doyle | Chief Medical Officer | Mar 16, 2026 | Option Exercise | $11.57 | 25,492 | $294.9K | 29,114 | |
AVTX | MITTIE DOYLE | — | Mar 16, 2026 | Proposed Sale | $15.80 | 29,529 | $466.6K | — |
← Previous
Page 2 of 2